A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to BioNTech SE
Related studies linked through entity extraction aliases.
Dose Escalation Trial of BNT152+153 in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults
- Status
- COMPLETED
- Phase
- PHASE4
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.
- Status
- COMPLETED
- Phase
- PHASE2
HARE-40: HPV Anti-CD40 RNA vaccinE
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1